{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:04:44Z","timestamp":1793639084823,"version":"4.5.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"DOI":"10.1186\/s12886-025-03971-7","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T12:59:16Z","timestamp":1751374756000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Optical coherence tomography angiography measurements in tamoxifen associated retinopathy: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"25","author":[{"given":"Mohammad Reza","family":"Abdol Homayuni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Sadeghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sepideh","family":"Poshtdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Ramandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Nikfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2058-9225","authenticated-orcid":false,"given":"Nazanin","family":"Ebrahimiadib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"issue":"18","key":"3971_CR1","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1093\/jnci\/90.18.1371","volume":"90","author":"B Fisher","year":"1998","unstructured":"Fisher B, Costantino JP, Wickerham DL, Redmond CK, Kavanah M, Cronin WM, et al. Tamoxifen for prevention of breast cancer: report of the National surgical adjuvant breast and bowel project P-1 study. J Natl Cancer Inst. 1998;90(18):1371\u201388.","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"3971_CR2","first-page":"315","volume":"62","author":"MI Kaiser-Kupfer","year":"1978","unstructured":"Kaiser-Kupfer MI, Lippman ME. Tamoxifen retinopathy. Cancer Treat Rep. 1978;62(3):315\u201320.","journal-title":"Cancer Treat Rep"},{"issue":"1","key":"3971_CR3","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.ajo.2007.03.023","volume":"144","author":"DH Bourla","year":"2007","unstructured":"Bourla DH, Sarraf D, Schwartz SD. Peripheral retinopathy and maculopathy in High-dose Tamoxifen therapy. Am J Ophthalmol. 2007;144(1):126\u20138.","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"3971_CR4","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1136\/bjo.65.3.177","volume":"65","author":"CA McKeown","year":"1981","unstructured":"McKeown CA, Swartz M, Blom J, Maggiano JM. Tamoxifen retinopathy. Br J Ophthalmol. 1981;65(3):177\u20139.","journal-title":"Br J Ophthalmol"},{"key":"3971_CR5","doi-asserted-by":"publisher","first-page":"175883592199343","DOI":"10.1177\/1758835921993436","volume":"13","author":"Y Su","year":"2021","unstructured":"Su Y, Zhang Y, Hua X, Huang J, Bi X, Xia W, et al. High-dose Tamoxifen in high-hormone-receptor-expressing advanced breast cancer patients: a phase II pilot study. Ther Adv Med Oncol. 2021;13:1758835921993436.","journal-title":"Ther Adv Med Oncol"},{"key":"3971_CR6","doi-asserted-by":"crossref","unstructured":"Chung H, Kim D, Ahn S-H, Kim J-G, Lee JY, Lim JY, et al. Early detection of tamoxifen-induced maculopathy in patients with low cumulative doses of tamoxifen. Ophthalmic Surgery, Lasers and Imaging Retina. 2010;41(3):1\u20135.","DOI":"10.3928\/15428877-20100215-06"},{"key":"3971_CR7","doi-asserted-by":"crossref","unstructured":"Gilman EA, Pruthi S, Hofstatter EW, Mussallem DM. Preventing breast cancer through identification and Pharmacologic management of High-Risk patients. Mayo Clin Proc. 2021;96(4):1033\u201340.","DOI":"10.1016\/j.mayocp.2021.01.028"},{"issue":"4","key":"3971_CR8","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.ajo.2005.04.042","volume":"140","author":"V Gualino","year":"2005","unstructured":"Gualino V, Cohen SY, Delyfer M-N, Sahel J-A, Gaudric A. Optical coherence tomography findings in Tamoxifen retinopathy. Am J Ophthalmol. 2005;140(4):757\u20138.","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"3971_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3928\/15428877-20100215-06","volume":"41","author":"H Chung","year":"2010","unstructured":"Chung H, Kim D, Ahn S-H, Kim J-G, Lee JY, Lim JY, et al. Early detection of Tamoxifen-induced maculopathy in patients with low cumulative doses of Tamoxifen. Ophthalmic Surg Lasers Imaging Retina. 2010;41(3):1\u20135.","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"issue":"6","key":"3971_CR10","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1016\/j.ajo.2014.02.046","volume":"157","author":"RR Doshi","year":"2014","unstructured":"Doshi RR, Fortun JA, Kim BT, Dubovy SR, Rosenfeld PJ. Pseudocystic foveal cavitation in Tamoxifen retinopathy. Am J Ophthalmol. 2014;157(6):1291\u2013e83.","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"3971_CR11","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.oret.2017.01.001","volume":"1","author":"B Todorich","year":"2017","unstructured":"Todorich B, Yonekawa Y, Thanos A, Randhawa S. OCT angiography findings in Tamoxifen maculopathy. Ophthalmol Retina. 2017;1(5):450\u20132.","journal-title":"Ophthalmol Retina"},{"issue":"8","key":"3971_CR12","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.oret.2019.03.014","volume":"3","author":"S Lee","year":"2019","unstructured":"Lee S, Kim H-A, Yoon YH. OCT angiography findings of Tamoxifen retinopathy: similarity with macular telangiectasia type 2. Ophthalmol Retina. 2019;3(8):681\u20139.","journal-title":"Ophthalmol Retina"},{"issue":"10","key":"3971_CR13","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.oftal.2020.05.028","volume":"95","author":"ML Mart\u00ednez","year":"2020","unstructured":"Mart\u00ednez ML, Bastien A, Giambruni JM, Bursztyn M, Ravazzola MN, Challiol CF. Toxicidad retiniana Por Tamoxifeno. Seguimiento mediante estudio Por imagen multimodal. Arch De La Sociedad Espa\u00f1ola De Oftalmolog\u00eda. 2020;95(10):496\u2013500.","journal-title":"Arch De La Sociedad Espa\u00f1ola De Oftalmolog\u00eda"},{"issue":"4","key":"3971_CR14","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.survophthal.2023.02.003","volume":"68","author":"F Bazvand","year":"2023","unstructured":"Bazvand F, Mahdizad Z, Mohammadi N, Shahi F, Mirghorbani M, Riazi-Esfahani H, et al. Tamoxifen Retinopathy Surv Ophthalmol. 2023;68(4):628\u201340.","journal-title":"Tamoxifen Retinopathy Surv Ophthalmol"},{"key":"3971_CR15","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.preteyeres.2012.11.002","volume":"34","author":"P Charbel Issa","year":"2013","unstructured":"Charbel Issa P, Gillies MC, Chew EY, Bird AC, Heeren TF, Peto T, et al. Macular telangiectasia type 2. Prog Retin Eye Res. 2013;34:49\u201377.","journal-title":"Prog Retin Eye Res"},{"issue":"11","key":"3971_CR16","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1016\/j.ophtha.2020.03.040","volume":"127","author":"TFC Heeren","year":"2020","unstructured":"Heeren TFC, Chew EY, Clemons T, Fruttiger M, Balaskas K, Schwartz R, et al. Macular telangiectasia type 2: visual acuity, disease end stage, and the MacTel area: MacTel project report number 8. Ophthalmology. 2020;127(11):1539\u201348.","journal-title":"Ophthalmology"},{"issue":"2","key":"3971_CR17","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.oret.2022.08.004","volume":"7","author":"K Hess","year":"2023","unstructured":"Hess K, Park YJ, Kim H-A, Holz FG, Issa PC, Yoon YH, et al. Tamoxifen retinopathy and macular telangiectasia type 2: similarities and differences on multimodal retinal imaging. Ophthalmol Retina. 2023;7(2):101\u201310.","journal-title":"Ophthalmol Retina"},{"issue":"3","key":"3971_CR18","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1097\/IAE.0000000000000863","volume":"36","author":"P Charbel Issa","year":"2016","unstructured":"Charbel Issa P, Heeren TF, Kupitz EH, Holz FG, Berendschot TT. VERY EARLY DISEASE MANIFESTATIONS OF MACULAR TELANGIECTASIA TYPE 2. Retina. 2016;36(3):524\u201334.","journal-title":"Retina"},{"issue":"6","key":"3971_CR19","doi-asserted-by":"publisher","first-page":"3905","DOI":"10.1167\/iovs.15-16915","volume":"56","author":"TF Heeren","year":"2015","unstructured":"Heeren TF, Clemons T, Scholl HP, Bird AC, Holz FG, Charbel Issa P. Progression of vision loss in macular telangiectasia type 2. Invest Ophthalmol Vis Sci. 2015;56(6):3905\u201312.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"3971_CR20","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1001\/jamaophthalmol.2014.3950","volume":"133","author":"RF Spaide","year":"2015","unstructured":"Spaide RF, Klancnik JM Jr., Cooney MJ. Retinal vascular layers in macular telangiectasia type 2 imaged by optical coherence tomographic angiography. JAMA Ophthalmol. 2015;133(1):66\u201373.","journal-title":"JAMA Ophthalmol"},{"issue":"11","key":"3971_CR21","doi-asserted-by":"publisher","first-page":"3479","DOI":"10.1007\/s00417-022-05695-6","volume":"260","author":"YJ Park","year":"2022","unstructured":"Park YJ, Lee S, Yoon YH. One-year follow-up of optical coherence tomography angiography microvascular findings: macular telangiectasia type 2 versus Tamoxifen retinopathy. Graefe\u2019s Archive Clin Experimental Ophthalmol. 2022;260(11):3479\u201388.","journal-title":"Graefe\u2019s Archive Clin Experimental Ophthalmol"},{"issue":"4","key":"3971_CR22","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1097\/IAE.0000000000000365","volume":"35","author":"FB Sallo","year":"2015","unstructured":"Sallo FB, Leung I, Clemons TE, Peto T, Bird AC, Pauleikhoff D. Multimodal imaging in type 2 idiopathic macular telangiectasia. Retina. 2015;35(4):742\u20139.","journal-title":"Retina"},{"issue":"9","key":"3971_CR23","doi-asserted-by":"publisher","first-page":"3683","DOI":"10.1167\/iovs.16-20976","volume":"58","author":"AP Runkle","year":"2017","unstructured":"Runkle AP, Kaiser PK, Srivastava SK, Schachat AP, Reese JL, Ehlers JP. OCT angiography and ellipsoid zone mapping of macular telangiectasia type 2 from the AVATAR study. Invest Ophthalmol Vis Sci. 2017;58(9):3683\u20139.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"3971_CR24","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1007\/s00417-019-04323-0","volume":"257","author":"D Pauleikhoff","year":"2019","unstructured":"Pauleikhoff D, Gunnemann F, Book M, Rothaus K. Progression of vascular changes in macular telangiectasia type 2: comparison between SD-OCT and OCT angiography. Graefes Arch Clin Exp Ophthalmol. 2019;257(7):1381\u201392.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"11","key":"3971_CR25","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1136\/bjophthalmol-2015-307941","volume":"100","author":"L Chidambara","year":"2016","unstructured":"Chidambara L, Gadde SG, Yadav NK, Jayadev C, Bhanushali D, Appaji AM, et al. Characteristics and quantification of vascular changes in macular telangiectasia type 2 on optical coherence tomography angiography. Br J Ophthalmol. 2016;100(11):1482\u20138.","journal-title":"Br J Ophthalmol"},{"key":"3971_CR26","first-page":"342","volume":"39","author":"K Magdalena","year":"2024","unstructured":"Magdalena K, Brzd\u0119k M, Winiarczyk M, Mackiewicz J, Kozie\u0142 D, Odrobina D, et al. Retinal thickness in patients with elevated D-dimer and interleukin-6 levels as a result of SARS-CoV-2 infection. Med Stud. 2024;39:342\u201351.","journal-title":"Med Stud"},{"key":"3971_CR27","doi-asserted-by":"crossref","unstructured":"Kal M, Brzd\u0119k M, Zar\u0119bska-Michaluk D, Pinna A, Mackiewicz J, Odrobina D, et al. Optical Coherence Tomography Angiography Assessment of the Optic Nerve Head in Patients Hospitalized Due to COVID-19 Bilateral Pneumonia. Medicina. 2024;60(3):502.","DOI":"10.3390\/medicina60030502"},{"issue":"1","key":"3971_CR28","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s13195-020-00638-x","volume":"12","author":"JY Lee","year":"2020","unstructured":"Lee JY, Kim JP, Jang H, Kim J, Kang SH, Kim JS, et al. Optical coherence tomography angiography as a potential screening tool for cerebral small vessel diseases. Alzheimers Res Ther. 2020;12(1):73.","journal-title":"Alzheimers Res Ther"},{"key":"3971_CR29","doi-asserted-by":"publisher","first-page":"21090","DOI":"10.1038\/srep21090","volume":"6","author":"R Agrawal","year":"2016","unstructured":"Agrawal R, Gupta P, Tan KA, Cheung CM, Wong TY, Cheng CY. Choroidal vascularity index as a measure of vascular status of the choroid: measurements in healthy eyes from a population-based study. Sci Rep. 2016;6:21090.","journal-title":"Sci Rep"},{"issue":"9","key":"3971_CR30","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1097\/IAE.0000000000001040","volume":"36","author":"R Agrawal","year":"2016","unstructured":"Agrawal R, Chhablani J, Tan KA, Shah S, Sarvaiya C, Banker A. CHOROIDAL VASCULARITY INDEX IN CENTRAL SEROUS CHORIORETINOPATHY. Retina. 2016;36(9):1646\u201351.","journal-title":"Retina"},{"issue":"4","key":"3971_CR31","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1167\/tvst.5.4.7","volume":"5","author":"R Agrawal","year":"2016","unstructured":"Agrawal R, Li LK, Nakhate V, Khandelwal N, Mahendradas P. Choroidal vascularity index in Vogt-Koyanagi-Harada disease: an EDI-OCT derived tool for monitoring disease progression. Transl Vis Sci Technol. 2016;5(4):7.","journal-title":"Transl Vis Sci Technol"},{"issue":"4","key":"3971_CR32","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1097\/IJG.0000000000001463","volume":"29","author":"HL Rao","year":"2020","unstructured":"Rao HL, Pradhan ZS, Suh MH, Moghimi S, Mansouri K, Weinreb RN. Optical coherence tomography angiography in glaucoma. J Glaucoma. 2020;29(4):312\u201321.","journal-title":"J Glaucoma"},{"issue":"3","key":"3971_CR33","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/ceo.13470","volume":"47","author":"A Invernizzi","year":"2019","unstructured":"Invernizzi A, Cozzi M, Staurenghi G. Optical coherence tomography and optical coherence tomography angiography in uveitis: A review. Clin Exp Ophthalmol. 2019;47(3):357\u201371.","journal-title":"Clin Exp Ophthalmol"},{"issue":"1","key":"3971_CR34","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1186\/s12886-022-02673-8","volume":"22","author":"K-Y Nam","year":"2022","unstructured":"Nam K-Y, Lee M-W, Lee K-H, Kim J-Y. Superficial capillary plexus vessel density\/deep capillary plexus vessel density ratio in healthy eyes. BMC Ophthalmol. 2022;22(1):482.","journal-title":"BMC Ophthalmol"},{"issue":"4","key":"3971_CR35","doi-asserted-by":"publisher","first-page":"354","DOI":"10.22336\/rjo.2019.55","volume":"63","author":"D Stana","year":"2019","unstructured":"Stana D, Potop V, Istrate SL, Eniceicu C, Mihalcea AR, Pa\u015fca IG, et al. Foveal avascular zone area measurements using OCT angiography in patients with type 2 diabetes mellitus associated with essential hypertension. Rom J Ophthalmol. 2019;63(4):354\u20139.","journal-title":"Rom J Ophthalmol"},{"key":"3971_CR36","unstructured":"Higgins JPT, Chandler JCM, Li T, Page MJ, Welch VATJ. Cochrane Handbook for Systematic Reviews of Interventions version 6.4 (updated August 2023). Cochrane 2023."},{"key":"3971_CR37","doi-asserted-by":"crossref","unstructured":"Schwarzer G, Carpenter J, R\u00fccker G. Meta-Analysis with R2015.","DOI":"10.1007\/978-3-319-21416-0"},{"issue":"11","key":"3971_CR38","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539\u201358.","journal-title":"Stat Med"},{"issue":"7109","key":"3971_CR39","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629\u201334.","journal-title":"BMJ"},{"issue":"6","key":"3971_CR40","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1097\/IAE.0000000000002533","volume":"40","author":"S Crisostomo","year":"2020","unstructured":"Crisostomo S, Vieira L, Cardigos J, Fernandes DH, Luis ME, Nunes S, et al. Tamoxifen-induced chorioretinal changes: an optical coherence tomography and optical coherence tomography angiography study. Retina. 2020;40(6):1185\u201390.","journal-title":"Retina"},{"key":"3971_CR41","doi-asserted-by":"crossref","unstructured":"Venkatesh R, Sharief S, Jayadev C, Gurram N, Mangla R, Agrawal R, et al. Tamoxifen retinopathy and macular telangiectasia: A comparative case series. European Journal of Ophthalmology. 2022;33:1156\u201364.","DOI":"10.1177\/11206721221142637"},{"issue":"1","key":"3971_CR42","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1034\/j.1600-0773.2002.910103.x","volume":"91","author":"M Engelke","year":"2002","unstructured":"Engelke M, Tykhonova S, Zorn-Kruppa M, Diehl H. Tamoxifen induces changes in the lipid composition of the retinal pigment epithelium cell line D407. Pharmacol Toxicol. 2002;91(1):13\u201321.","journal-title":"Pharmacol Toxicol"},{"issue":"9","key":"3971_CR43","doi-asserted-by":"publisher","first-page":"5344","DOI":"10.1167\/iovs.12-9827","volume":"53","author":"KS Cho","year":"2012","unstructured":"Cho KS, Yoon YH, Choi JA, Lee SJ, Koh JY. Induction of autophagy and cell death by Tamoxifen in cultured retinal pigment epithelial and photoreceptor cells. Invest Ophthalmol Vis Sci. 2012;53(9):5344\u201353.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"3971_CR44","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1034\/j.1600-0773.2002.910305.x","volume":"91","author":"H M\u00e4enp\u00e4\u00e4","year":"2002","unstructured":"M\u00e4enp\u00e4\u00e4 H, Mannerstr\u00f6m M, Toimela T, Salminen L, Saransaari P, T\u00e4hti H. Glutamate uptake is inhibited by Tamoxifen and Toremifene in cultured retinal pigment epithelial cells. Pharmacol Toxicol. 2002;91(3):116\u201322.","journal-title":"Pharmacol Toxicol"},{"issue":"2","key":"3971_CR45","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1254\/jphs.08039SC","volume":"107","author":"K Sato","year":"2008","unstructured":"Sato K, Saito Y, Oka J-i, Ohwada T, Nakazawa K. Effects of Tamoxifen on L-Glutamate transporters of astrocytes. J Pharmacol Sci. 2008;107(2):226\u201330.","journal-title":"J Pharmacol Sci"},{"issue":"3","key":"3971_CR46","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1152\/physrev.00021.2004","volume":"85","author":"O Strauss","year":"2005","unstructured":"Strauss O. The retinal pigment epithelium in visual function. Physiol Rev. 2005;85(3):845\u201381.","journal-title":"Physiol Rev"},{"issue":"1","key":"3971_CR47","doi-asserted-by":"publisher","first-page":"17198","DOI":"10.1038\/s41598-021-96789-4","volume":"11","author":"Y-R Chung","year":"2021","unstructured":"Chung Y-R, Kim YH, Oh J, Kim S-W, Lee CS, Yun C, et al. Characterizing right-angled vessel in macular telangiectasia type 2 with structural optical coherence tomography. Sci Rep. 2021;11(1):17198.","journal-title":"Sci Rep"},{"issue":"9","key":"3971_CR48","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1136\/bjophthalmol-2018-313364","volume":"105","author":"S Tzaridis","year":"2021","unstructured":"Tzaridis S, Heeren T, Mai C, Thiele S, Holz FG, Charbel Issa P, et al. Right-angled vessels in macular telangiectasia type 2. Br J Ophthalmol. 2021;105(9):1289\u201396.","journal-title":"Br J Ophthalmol"},{"key":"3971_CR49","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.visres.2017.03.013","volume":"139","author":"BA Coughlin","year":"2017","unstructured":"Coughlin BA, Feenstra DJ, Mohr S. M\u00fcller cells and diabetic retinopathy. Vis Res. 2017;139:93\u2013100.","journal-title":"Vis Res"},{"issue":"5","key":"3971_CR50","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s00417-006-0516-y","volume":"245","author":"A Reichenbach","year":"2007","unstructured":"Reichenbach A, Wurm A, Pannicke T, Iandiev I, Wiedemann P, Bringmann A. M\u00fcller cells as players in retinal degeneration and edema. Graefe\u2019s Archive Clin Experimental Ophthalmol. 2007;245(5):627\u201336.","journal-title":"Graefe\u2019s Archive Clin Experimental Ophthalmol"},{"issue":"45","key":"3971_CR51","doi-asserted-by":"publisher","first-page":"15715","DOI":"10.1523\/JNEUROSCI.2841-12.2012","volume":"32","author":"W Shen","year":"2012","unstructured":"Shen W, Fruttiger M, Zhu L, Chung SH, Barnett NL, Kirk JK, et al. Conditional m\u00fcllercell ablation causes independent neuronal and vascular pathologies in a novel Transgenic model. J Neurosci. 2012;32(45):15715\u201327.","journal-title":"J Neurosci"},{"issue":"4","key":"3971_CR52","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1111\/joa.12653","volume":"231","author":"R Bejarano-Escobar","year":"2017","unstructured":"Bejarano-Escobar R, S\u00e1nchez-Calder\u00f3n H, Otero-Arenas J, Mart\u00edn-Partido G, Francisco-Morcillo J. M\u00fcller glia and phagocytosis of cell debris in retinal tissue. J Anat. 2017;231(4):471\u201383.","journal-title":"J Anat"},{"issue":"4","key":"3971_CR53","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.ophtha.2019.10.038","volume":"127","author":"H-A Kim","year":"2020","unstructured":"Kim H-A, Lee S, Eah KS, Yoon YH. Prevalence and risk factors of Tamoxifen retinopathy. Ophthalmology. 2020;127(4):555\u20137.","journal-title":"Ophthalmology"},{"issue":"11","key":"3971_CR54","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1016\/j.ophtha.2013.04.013","volume":"120","author":"MB Powner","year":"2013","unstructured":"Powner MB, Gillies MC, Zhu M, Vevis K, Hunyor AP, Fruttiger M. Loss of M\u00fcller\u2019s cells and photoreceptors in macular telangiectasia type 2. Ophthalmology. 2013;120(11):2344\u201352.","journal-title":"Ophthalmology"},{"issue":"12","key":"3971_CR55","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1093\/abbs\/gmaa127","volume":"52","author":"Y Xu","year":"2020","unstructured":"Xu Y, Zhu Y, Yue Y, Pu S, Wu J, Lv Y, et al. Tamoxifen attenuates reactive astrocyte-induced brain metastasis and drug resistance through the IL-6\/STAT3 signaling pathway. Acta Biochim Biophys Sin (Shanghai). 2020;52(12):1299\u2013305.","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"issue":"1","key":"3971_CR56","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13058-021-01412-z","volume":"23","author":"SY Wu","year":"2021","unstructured":"Wu SY, Sharma S, Wu K, Tyagi A, Zhao D, Deshpande RP, et al. Tamoxifen suppresses brain metastasis of Estrogen receptor-deficient breast cancer by skewing microglia polarization and enhancing their immune functions. Breast Cancer Res. 2021;23(1):35.","journal-title":"Breast Cancer Res"},{"key":"3971_CR57","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.phrs.2018.03.021","volume":"132","author":"N Shah","year":"2018","unstructured":"Shah N, Mohammad AS, Saralkar P, Sprowls SA, Vickers SD, John D, et al. Investigational chemotherapy and novel Pharmacokinetic mechanisms for the treatment of breast cancer brain metastases. Pharmacol Res. 2018;132:47\u201368.","journal-title":"Pharmacol Res"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-025-03971-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-025-03971-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-025-03971-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T01:05:58Z","timestamp":1751418358000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-025-03971-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3971"],"URL":"https:\/\/doi.org\/10.1186\/s12886-025-03971-7","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"3 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"373"}}